Substitution of Nevirapine, Efavirenz, or Abacavir for Protease Inhibitors in Patients with Human Immunodeficiency Virus Infection-Reference-Cited by-同舟云学术

Substitution of Nevirapine, Efavirenz, or Abacavir for Protease Inhibitors in Patients with Human Immunodeficiency Virus Infection

Published:2003-09-11 Issue:11 Volume:349 Page:1036-1046
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Martínez Esteban,Arnaiz Juan A.,Podzamczer Daniel,Dalmau David,Ribera Esteban,Domingo Pere,Knobel Hernando,Riera Melcior,Pedrol Enric,Force Lluis,Llibre Josep M.,Segura Ferran,Richart Cristóbal,Cortés Cristina,Javaloyas Manuel,Aranda Miquel,Cruceta Ana,de Lazzari Elisa,Gatell José M.

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa021589

Cited by 265 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BHIVA guidelines on antiretroviral treatment for adults living with HIV‐1 2022;HIV Medicine;2022-12

2. Factors associated with viral suppression and rebound among adult HIV patients on treatment: a retrospective study in Ghana;AIDS Research and Therapy;2022-05-25

3. Impact of previous HIV resistance and virologic failures on virologic outcome following a switch to dolutegravir with 2 NRTIs among people living with HIV;Medicine;2020-11-20

Antiretroviral Therapy-Associated Metabolic Complications: Review of the Recent Studies

;HIV/AIDS - Research and Palliative Care;2020-10

5. Global Frequencies of Clinically Important HLA Alleles and Their Implications For the Cost‐Effectiveness of Preemptive Pharmacogenetic Testing;Clinical Pharmacology & Therapeutics;2020-07-26